首页|冠心康通过肝胞葬作用改善LDLR-/-动脉粥样硬化模型小鼠肝脏脂肪变性的机制研究

冠心康通过肝胞葬作用改善LDLR-/-动脉粥样硬化模型小鼠肝脏脂肪变性的机制研究

扫码查看
目的 通过观察冠心康对肝胞葬作用的影响,探讨冠心康改善LDLR-/-动脉粥样硬化(atherosclerosis,AS)模型小鼠肝脏脂肪变性的可能机制。方法 选取LDLR-/-小鼠西方饮食制备AS模型,随机分为模型组、冠心康组和阿托伐他汀组,另取C57BL/6J小鼠作为对照组。干预结束后,检测血清天门冬氨酸氨基转移酶(Aspartate Aminotransferase,ALT)、谷草转氨酶(Aspartate Transaminase,AST)、总胆固醇(Total cholesterol,TC)、甘油三酯(Triglyceride,TG)含量;HE 和油红O染色观察主动脉和肝组织病理变化;RT-qPCR和Western blot法分别检测肝脏1-磷酸-鞘氨醇受体1(Sphingosine-1-phosphate,S1P1)、趋化因子受体 1(Chemokine C-X3-C-Motif Receptor 1,CX3CR1)、酪氨酸激酶(MER proto-onco-gene tyrosine kinase,MERTK)、乳脂球表皮生长因子 8(Recombinant Milk Fat Globule EGF Factor 8,MFGE8)mRNA 和蛋白相对表达量;免疫荧光法检测肝脏胞葬信号和凋亡细胞表达。结果 与对照组相比,模型组小鼠主动脉窦斑块明显增大(P<0。01),血清ALT、AST、TC、TG水平显著升高(P<0。01),肝组织可见病理变化和脂肪样变性,肝脏S1P1、CX3CR1、MERTK、MFGE8 mRNA和蛋白相对表达量显著降低(P<0。01),S1P1信号表达减弱(P<0。05)、Caspase-3(P<0。01)信号表达增强;与模型组相比,冠心康及阿托伐他汀组小鼠主动脉窦斑块明显减小(P<0。01),冠心康组小鼠血清ALT、AST、TC、TG水平显著降低(P<0。01),肝组织病理改变及脂肪样变性好转,S1P1、CX3CR1、MERTK、MFGE8mRNA和蛋白相对表达量显著升高(P<0。01),S1P1信号表达增强(P<0。01)、Caspase-3信号表达减弱(P<0。01);结论 冠心康可能通过促进肝胞葬作用改善LDLR-/-AS模型小鼠肝脏脂肪变性。
Mechanism of Guanxinkang ameliorating hepatic steatosis by liver efferocytosis in LDLR-/-atherosclerosis model mice
Objective The research aims to observe the effect of Guanxinkang decoction on liver steatosis in LDLR-/-atheroscle-rosis mice through liver efferocytosis.Methods Eighteen LDLR-/-mice were randomly divided into model group,Guanxinkang decoction group and atorvastatin group.After 12 weeks of high-fat diet,the model group,Guanxinkang decoction group and atorvastatin group were treated with normal saline,Guanxinkang decoction 28.66g/(kg·d)and atorvastatin suspension 5 mg/(kg·d)by gavage for 12 weeks,respectively.Another six C57BL/6J mice were used as the normal control group,and were fed with normal diet for 24 weeks.The levels of serum Aspartate Aminotransferase(ALT),Aspartate Transaminase(AST),total choles-terol(TC)and Triglyceride(TG)were detected by automatic biochemical analyzer;HE and oil red O staining was used to ob-serve the pathological changes of aortic sinus and liver tissue.RT-qPCR and Western blot were used to detect liver Sphingosine-1-phosphate Receptor 1(S1P1)and Chemokine C-X3-C-Motif receptor 1(CX3CR1),MER proto-oncogene tyrosine ki-nase(MERTK)and Recombinant Milk Fat Globule EGF Factor 8(MFGE8)mRNA and protein relative expression.Re-sults Compared with the control group,the serum levels of ALT,AST,TC,and TG in the model group were significantly in-creased(P<0.01),and pathological changes and steatosis were observed in the liver tissue.The relative expressions of S1P1,CX3CR1,MERTK,and MFGE8mRNA and protein in the liver were significantly decreased(P<0.01).Compared with the model group,the serum levels of ALT,AST,TC and TG in the Guanxinkang decoction group were significantly decreased(P<0.01),the pathological changes and steatosis of liver tissue were improved,and the relative expressions of S1P1,CX3CR1,MERTK and MFGE8mRNA and protein were significantly increased(P<0.01).Conclusion Guanxinkang decoction may im-prove liver steatosis in LDLR-/-AS model mice by promoting liver efferocytosis.

GuanxinkangLiver efferocytosisLDLR--miceAtherosclerosisLiver steatosis

王佳柔、冯骁腾、杜敏、张一凡、李斯锦、常鑫迪、刘萍

展开 >

上海中医药大学附属龙华医院,上海 200032

冠心康 肝胞葬作用 LDLR-/-小鼠 动脉粥样硬化 肝脂肪变性

国家自然科学基金面上项目

81873117

2024

时珍国医国药
时珍国医国药杂志社

时珍国医国药

北大核心
影响因子:0.887
ISSN:1008-0805
年,卷(期):2024.35(5)